Drugs of Abuse Flashcards

1
Q

What is Drug Abuse?

A

• Abuse is the excessive self-administration of
any substance for nonmedical purposes.
• Some drugs of abuse do not lead to addiction.
• This is the case of substances that alter
perception without causing sensations of reward
and euphoria, such as the hallucinogens.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What behaviors indicate addiction?

A
Behaviors that include one or more of the following:
• impaired control over drug use
• compulsive use
• continued use despite harm
• craving
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is physical dependence and how can withdrawal syndrome be reproduced?

A

• State of adaptation manifested by drug class
specific withdrawal syndrome.
• The withdrawal syndrome can be produced by:
• abrupt cessation
• rapid dose reduction
• administration of an antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is withdrawal syndrome?

A

• Physiological and behavioral changes directly

related to sudden cessation or reduction in use of a drug to which the body has become adapted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is considered tolerance?

A

• A state of adaptation in which exposure to a
drug induces changes that result in a diminution
of one or more of the drug’s effects over time.
• Tolerance may occur to both the desired and
undesired effects of drugs, and may develop at
different rates for different effects.
Physical dependence and Tolerance
• Normal responses that often occur with the
persistent use of certain medications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanisms of Addiction?

A

• The mesolimbic dopamine system is the prime
target of addictive drugs.
• As a general rule, all addictive drugs activate
the mesolimbic dopamine system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of drugs of abuse?

A
  • CNS DEPRESSANTS
  • PSYCHOSTIMULANTS
  • NICOTINE
  • OPIOIDS
  • MARIJUANA
  • PSYCHEDELIC AGENTS
  • INHALANTS
  • ANABOLIC STEROIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

list 3 cns depressants?

A
  • Ethanol
  • Benzodiazepines
  • Barbiturates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ethanol classification and moa?

A

• Ethanol is classed as a depressant because it
produces sedation and sleep.
• The initial effects of ethanol are often perceived
as stimulation due to suppression of inhibitory
systems.
• Ethanol influences several cellular functions:
• GABAA receptors
• Kir3/GIRK channels
• Adenosine reuptake
• Glycine receptors
• NMDA receptors
• 5-HT3 receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe ethanol withdrawal syndrome?

A

• Heavy consumption of ethanol leads to acquired
tolerance and physical dependence.
• Withdrawal syndrome may include tremor, nausea, vomiting, sweating, agitation and anxiety.
• This may be followed by hallucinations.
• Generalized seizures may appear after 24-48 h.
• After 48-72 h delirium tremens may appear.
• Delirium tremens is associated with 5-15%
mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TREATMENT OF ALCOHOL WITHDRAWAL?

A

• Long half-life benzodiazepines are the preferred agents: Diazepam and chlordiazepoxide.
• Because of their long half-life, withdrawal is smoother, and rebound withdrawal symptoms are less likely.
• Lorazepam and oxazepam are intermediateacting drugs.
• They may be preferable in the elderly and
those with liver failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment of alcohol addiction?

A
• Three drugs are FDA-approved for treatment of
alcoholism:
• Disulfiram: Aldehyde dehydrogenase
inhibitor. Used to create aversion to drinking.
• Naltrexone: Orally available opioid
antagonist. Reduces craving for alcohol.
• Acamprosate: NMDA receptor antagonist.
Prevents relapse.
Topiramate
• Facilitates GABA function, antagonizes
glutamate receptors.
• May reduce cravings.
• Not FDA-approved.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Benzodiazepine overview, withdrawal syndrome, and management of withdrawal?

A

• Can cause physical dependence and addiction.
• Addiction is rare.
• Signs and symptoms include: tremors, anxiety,
perceptual disturbances, dysphoria, psychosis,
and seizures.
• The syndrome can be life-threatening.
• If the patient is on a short-acting drug, they are
switched to a long-acting drug.
• Diazepam is the most used agent.
• Then the dose is gradually reduced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does barbiturate abuse resemble?

A

• Abuse problems with barbiturates resemble those seen with benzodiazepines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List three psychostimulants?

A
  • Methylxanthines
  • Cocaine
  • Amphetamines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List 3 methylxanthines and moa?

A

• Caffeine, theophylline & theobromine.
• Caffeine is the most widely consumed stimulant.
• Methylxanthines block presynaptic adenosine
receptors.
• Activation of adenosine receptors inhibits
norepinephrine release.
• Therefore blockade of adenosine receptors
increases norepinephrine release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Actions of caffeine dose on CNS?

A

CNS
• 100–200 mg caffeine (1 - 2 cups of coffee) cause decrease in fatigue and increased mental
alertness.
• 1.5 g caffeine (12 to 15 cups of coffee) produces
anxiety and tremors.
• The spinal cord is stimulated only by very high
doses (2–5 g) of caffeine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

METHYLXANTHINES:

TOLERANCE AND WITHDRAWAL

A

• Tolerance can rapidly develop to the stimulating
properties of caffeine.
• Withdrawal consists of feelings of fatigue and
sedation.
• Addiction is rare.
• Caffeine is not listed in the category of addicting
stimulants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cocaine overview and moa?

A

• Due to its abuse potential, cocaine is classified
as a Schedule II drug by the DEA.
• Cocaine inhibits dopamine, norepinephrine and
serotonin reuptake.
• The prolongation of dopaminergic effects in the
brain’s limbic system produces the intense
euphoria that cocaine initially causes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cocaine’s action on the cns?

A

CNS
• Stimulation of cortex and brainstem.
• Increases mental awareness and produces a
feeling of well-being and euphoria.
• Paranoia may occur after repeated doses.
• At high doses: tremors and convulsions, followed by respiratory and vasomotor
depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cocaine action on the SNS?

A

SYMPATHETIC NERVOUS SYSTEM
• Peripherally, cocaine potentiates the action of
norepinephrine resulting in adrenergic
stimulation.
• Adrenergic stimulation produces tachycardia,
hypertension, mydriasis, and diaphoresis

22
Q

Describe cocaine withdrawal syndrome?

A

• Dysphoria, depression, sleepiness, fatigue, cocaine craving and bradycardia.
• Cocaine withdrawal is generally mild.
• Treatment of withdrawal symptoms is usually not
required.
• Many agents, mainly antidepressants and
dopamine agonists have been tested as treatments for cocaine abuse.
• None have demonstrated clear efficacy

23
Q

Amphetamines overview and moa?

A

• Amphetamines are classified as Schedule II
drugs by the DEA.
• Amphetamines increase release of catecholamines.
• They are also weak inhibitors of MAO.
• They are also possible direct catecholaminergic
agonists in the brain.

24
Q

AMPHETAMINES: ACTIONS on CNS and SNS?

A

CNS
• Behavioral effects similar to those of cocaine.
• Due to release of dopamine.
• Increased alertness, decreased fatigue,
depressed appetite and insomnia.
• At high doses, psychosis and convulsions.
SYMPATHETIC NERVOUS SYSTEM
• Activate receptors through norepinephrine
release.

25
Q

Amphetamine uses?

A

• Attention deficit syndrome: Amphetamine and
methylphenidate.
• Narcolepsy: Amphetamine and methylphenidate.

26
Q

Describe amphetamine tolerance and withdrawal?

A
• Tolerance can be marked.
• An abstinence syndrome can occur upon
withdrawal.
• Symptoms include increased appetite,
sleepiness, exhaustion, and mental depression.
• Antidepressants may be indicated.
27
Q

Nicotine overview and moa?

A

• Second only to caffeine as the most widely used
CNS stimulant.
• Second only to alcohol as the most abused drug.
• Full agonist of the nicotine receptor.
• The rewarding effect of nicotine requires
involvement of the ventral tegmental area ,
where nicotinic receptors are expressed on
dopamine neurons.
• When nicotine excites these neurons, dopamine
is released.

28
Q

Nicotine actions?

A

• In low doses: ganglionic stimulation by
depolarization.
• At high doses: ganglionic blockade.
CNS
• Cigarette smoking or administration of low doses
of nicotine produces some degree of euphoria
and relaxation.
• Improves attention, learning, problem solving,
and reaction time.
• High doses of nicotine result in central
respiratory paralysis and severe hypotension
caused by medullary paralysis.
• Nicotine is an appetite suppressant.

29
Q

Describe nicotine withdrawal symptoms?

A

• Nicotine withdrawal is mild.
• Involves irritability and sleeplessness.
• However, nicotine is among the most addictive
drugs.
• Relapse is very common.

30
Q

Treatment for nicotine addiction?

A

NICOTINE REPLACEMENT THERAPY
• Nicotine can be administered by transdermal
patch, gum, nasal spray, vapor inhaler or by
lozenge for buccal absorption.

SUSTAINED-RELEASE BUPROPION
• MOA unclear.

VARENICLINE
• Partial agonist at nicotinic receptors in the CNS.
• Reduces the reward of smoking.

31
Q

4 most common opioids and describe opioid tolerance, dependence, and addiction?

A

• All opioids induce strong tolerance and dependence.
• Addiction to heroin or other short-acting opioids
produces behavioural disruptions and usually is
incompatible with a productive life.
• The withdrawal syndrome is unpleasant but not
life-threatening.
• It includes dysphoria, lacrimation, rhinorrhea and
yawning.

32
Q

OPIOIDS: TREATMENT OF OPIOID WITHDRAWAL?

A

DETOXIFICATION USING OPIOID AGONISTS
• The illicit agent is replaced by a long-acting opioid.
• The dose is slowly reduced.
• Drugs used: Methadone or buprenorphine.
• Methadone is a useful drug for detoxification and
maintenance of the chronic relapsing heroin addict.

33
Q

Describe DETOXIFICATION USING OPIOID ANTAGONISTS?

A

• Naltrexone is an antagonist with a high affinity for the μ opioid receptor.
• Naltrexone will not satisfy craving or relieve withdrawal symptoms.
• Naltrexone can be used after detoxification for
patients with high motivation to remain opioidfree.

34
Q

Overview of Marijuana?

A

• The smoke from burning cannabis contains 61
different cannabinoids.
• D9-tetrahydrocannabinol (D9-THC, THC,
dronabinol) produces most of the effects.

35
Q

MARIJUANA: MECHANISM OF ACTION?

A

• Two cannabinoid receptor subtypes:CB1 & CB2.
• Both are G protein-linked receptors.
• Both couple to Gi.
• CB1 receptors are found primarily in the brain
and mediate the psychological effects of THC.
• CB2 receptors are present mainly on immune
cells.

36
Q

MARIJUANA: ACTIONS? Tolerance and dependence?

A

• THC can produce euphoria, followed by
drowsiness and relaxation.
• Affects short-term memory and mental activity.
• Impairs highly skilled motor activity.
• Other effects: appetite stimulation, xerostomia,
visual hallucinations, delusions, enhancement of
sensory activity.
• At high doses: toxic psychosis.
• Tolerance and mild physical dependence occur
with continued, frequent use of the drug.

37
Q

MARIJUANA: USES?

A

• Therapeutic THC is called dronabinol.
• Dronabinol is FDA-approved for:
• Anorexia associated with weight loss in
patients with AIDS.
• Nausea and vomiting associated with cancer
chemotherapy (second line).

38
Q

List 5 PSYCHEDELIC AGENTS

A
• LSD
• MESCALINE
• PSILOCYBIN
• PHENCICLIDINE
• MDMA
• Psychedelic drugs affect thought, perception and
mood.
• They don’t cause marked psychomotor
stimulation or depression.
39
Q

3 lsd like group of drugs?

A

The LSD-like group of drugs include:
• LSD
• Mescaline
• Psilocybin

40
Q

LSD moa?

A

• The hallucinogenic actions of LSD appear to be
mediated by agonist effects at 5-HT2 receptors
in the CNS.

41
Q

LSD: CLINICAL PRESENTATION?

A

• Patients who have taken LSD generally present
with a combination of somatic and psychomimetic symptoms.
• Somatic symptoms are usually due to sympathomimetic effects.
• Somatic symptoms include: mydriasis, hypertension, tachycardia, increased body
temperature, flushing, sweating, tremors and
piloerection.

42
Q

LSD: PHYSICAL DEPENDENCE AND

WITHDRAWAL and AE?

A

• LSD does not cause addiction.
• There is no withdrawal syndrome.
• Users may require medical attention because of
“bad trips”.
• Severe agitation may require medication:
diazepam is effective.

43
Q

Overview and actions of Phencyclidine?

A

• Dissociative anesthetic.
• Blocks reuptake of norepinephrine and
dopamine.
• Causes cholinergic and anticholinergic effects.
• Has actions at nicotinic and opioid receptors.
• The dissociative properties of PCP are believed
to be due to non-competitive antagonism at
NMDA receptors.

44
Q

PHENCYCLIDINE: CLINICAL PRESENTATION?

A

• Clinical manifestations include violent or bizarre
behavior, psychosis, nystagmus, tachycardia,
hypertension, diaphoresis, miosis, anesthesia,
and analgesia.
• An important diagnostic clue is nystagmus.

45
Q

PHENCYCLIDINE: TREATMENT?

A
  • There is no specific antidote for PCP.
  • Extreme violent psychotic behavior requires sedation with parenteral benzodiazepines.
  • Seizures should be treated with benzodiazepines.
46
Q

Overview of MDMA(ecstasy)?

A

• MDMA fosters feelings of empathy and intimacy
without impairing intellectual capacities.
• MDMA causes release of biogenic amines.
• It most strongly increases the concentration of
serotonin in the synaptic cleft.
• Withdrawal is characterized by depression, lasting up to several weeks.
• MDMA produces degeneration of serotonergic
neurons in rats.

47
Q

Name 3 inhalants?

A
  • NITROUS OXIDE
  • VOLATILE ORGANIC SOLVENTS
  • ORGANIC NITRITES
48
Q

Effects of Nitrous oxide?

A

NITROUS OXIDE
• Produces euphoria and analgesia and then loss
of consciousness.
• Usually taken as 35% N2O mixed with O2.
• Administration of 100% N2O may cause
asphyxia and death

49
Q

What are categorized under volatile organic solvents, effects, and toxicities?

A

VOLATILE ORGANIC SOLVENTS
• Include gasoline, paint thinner, lighter fluid, glue
and degreasers.
• Produce sense of exhilaration and lightheadedness.
• Toxicity depends on the properties of individual
solvents.
• Implicated in cancer, cardiotoxicity, neuropathies
and hepatotoxicity.

50
Q

Describe organic nitrites?

A

ORGANIC NITRITES
• Amyl nitrite and butyl nitrite are used to enhance
erection.
• They are not addictive.

51
Q

What are anabolic steroids used for?

A

• Used to increase muscle size by body-building

competitors.